Abstract: A novel palladium catalyzed synthesis of the benzofuran analogue 11 of n-hexyl-ILV and details of its isoform selectivity are described. Of considerable interest is the unexpected finding that this subtle structural change leads to a compound that is more like phorbol 12,13-dibutyrate (PDBu) and less like noctyl-ILV in its pattern of activity.
Molecular cloning analysis has revealed that the calciudphospholipid-dependent protein kinase C (PKC) is comprised of a family of at least ten individual isoforms. According to their structural organization and their sensitivity to Ca2+, these isoforms have been classified into three groups: the classical PKCs (a, PI, PII, and y) require Ca*+ for full activation, while the new PKCs (6, E, 7 , and 0) and atypical PKCs (6, 1) are CaZ+ independent.1 It is believed that each of these PKC isoforms may play a specific role in cell type-specific processes like endocytosis, secretion, growth, or differentiation.], 2 While much attention has focused on the elucidation of the roles of the individual PKC isoforms in the past few years, this research has been hindered by the lack of small molecules that can selectively activate or inhibit either the individual isoforms or a small group of these isoforms.l.2
Physiologically, PKC is activated by diacyl glycerols (DAGs), which result from the agonistinduced hydrolysis of membrane phospholipids. l13 The DAG drives the translocation of the inactive, cytoplasmic PKC to the membrane, where it interacts with other phospholipids such as phosphatidylserine and becomes fully activated. Several complex natural products and their derivatives like the phorbol esters, bryostatins, and teleocidins including indolactam V (ILV) can mimic DAG to activate PKC at low concentration^.^ However, unlike DAG, these molecules can cause depletion, or down-regulation, of cellular PKC through its prolonged a~tivation.~ Preliminary studies have shown that these ligands exhibit some differential isoform selectivity for binding in vitro and cause differential isoform translocation and down-regulation in viv0.5, 6 For example, the mezerein analogue thymeleatoxin showed 20-fold lower affinity for PKCE than for PKCP. In contrast, phorbol 12,13-dibutyrate (PDBu) showed a 5-fold spread in affinities and DAG only a 1.7-fold difference between isoforms. 6 The discovery of other isoform-selective agents thus appears worthwhile in further defining the roles of the PKC isoforms, and as well in generating new agents for cancer ~hemotherapy.~?~ In comparison with the phorbol esters, little information is available regarding the isoform selectivity of the teleocidin family. Blumberg has reported recently that 7-n-octyl-indolactam V exhibits little if any selectivity for the isoforms tested.6 In order to probe the possibility of developing isotype selective agents based on the ILV structure,9 we sought to explore replacement of the indole nucleus by a benzofuran ring.10 Herein we describe a novel synthesis of the benzofuran analogue 11 of n-hexyl-ILV and its biological evaluation. 1 1 As detailed in the accompanying Scheme I, this benzofuran analogue was assembled enantioselectively starting from the N-pivaloyl derivative of m-anisidine 1, which was converted to the bromide 2 through a directed ortho-metalation reaction.I2 The Friedel-Crafts reaction of 2 with nhexanoyl chloride at 70 "C for 2 days accompanied by 0-demethylation afforded ketone 3 in 41% yield. After failure to reduce the acyl group to an alkyl group by use of Hz/catalyst or LAWAlC13, we found that treatment of 3 with ethyl chloroformate followed by reduction with NaBH4 gave the desired product 4 in excellent yield.I3 The pivaloyl protecting group was then removed by refluxing 4 in HCl/ethanol to afford 5 . This anisidine derivative was reacted with the D-serine derived allyl alcohol 7 under Mitsunobu conditions to produce 8 in 75% yield. Synthesis of the allyl alcohol 7 ([a]22D = +23.1", c 0.12, EtOAc) was carried out starting from aldehyde 614 by the standard sequence of operations detailed at the bottom of Scheme I. Subjection of the ether derivative 8 to Larock's intramolecular cyclization protocol employing Jeffrey's palladium catalyst system and sodium formate as the reducing agent led in turn to the benzofuran 9 = -23.3", c 0.12, EtOAc) in 83% yield.15 Next, the reaction of 9 with the D-valine derived triflate 12 was carried out under basic conditions to afford compound 10 ([a]22D = -42.7", c 1.14, EtOAc).l6 Lastly, the three protecting groups of 10 were removed in one pot by Pd/C catalyzed hydrogenation and hydrolysis with a 1:l mixture of concentrated HC1 and ethanol. The resulting amino acid hydrochloride was immediately treated with BOP, HOBt, and N-methylmorpholine in DMF to generate the lactam ring, and then the a m h e nitrogen was N-methylated to furnish 11 ([a]22D
Compound 11 was evaluated for its ability to inhibit [3H]PDBu binding to recombinant PKCa, PKCP, PKCy, PKCG, and PKCE employing the same experimental protocol described elsewhere. 6 We found that 11 exhibited modestly weaker affinity for PKCG (12.3 zk 3.4 nM), PKCE (8.0 f 2.1 nM), and PKCy (6.4 zk 0.5 nM) than for PKCa (4.0 f 0.7 nM) and PKCPI (2.3 f 0.5 nM, n = 6 ) . Relative affinities are shown in graphical form in Figure 1 . These results indicate that this new analogue exhibits a pattern of activity which is modestly more like that for PDBu and less like that for 7-n-octyl-ILV and ILV.6 Compound 11 was also shown to stimulate PKC enzymatic activity to the same maximal extent as PDBu. Our idea of pursuing further structural modifications of ILV in order to obtain agents exhibiting improved levels of isoform selectivity thus appears to be reasonably well founded.
The above findings reveal that the absence of the indole NH does not have a deleterious effect on the ability of the benzofuran analogue to activate PKC. Moreover, our findings reveal that the ring heteroatom of the ILV analogues plays a role in the recognition of these molecules by the different isoforms of PKC. While this result is somewhat unexpected, and may be related to differences in H bond donor/acceptor character of N and 0, a more complete understanding of the subtleties of the = -175.8", c 0.24, EtOAc). molecular recognition process at the atomic level will require detailed NMR/x-ray studies of the individual complexes formed from these small molecules and the various isotypes of PKC.6
